How to transition existing trials under EU-CTR

Published on: Feb 1, 2023

Return to Insights Center

Related Insights

Video

Part 3: Risk-based Quality Management Video (RBQM) Series

Nov 11, 2021

Article

Decentralized trial tools and technologies are here to stay: A regulatory perspective

Jul 23, 2021

Video

Part 2: Risk-based Quality Management Video (RBQM) Series

Nov 11, 2021

Webinar

Accelerating delivery of radiopharmaceutical trials

Oct 3, 2025

Report

New Medicines, Novel Insights: Advancing rare disease drug development

May 22, 2023

Report

New Medicines, Novel Insights: Accelerating development of cell and gene therapies

May 22, 2023

Article

Australia: The Regulatory and Reimbursement Environment

Aug 28, 2023

Article

How a joined-up development strategy pays off for early-stage biotechs

May 19, 2021

Article

Part 1 - Preparing for a Risk-Based Future: What ICH Revisions Mean for Clinical Trial Design and Conduct

Sep 14, 2021

Blog

Generative AI and how we can harness its power in clinical development

Sep 26, 2023

Blog

Assessing the need for comparative clinical trials in biosimilar development programs

Sep 21, 2023

Whitepaper

Scientific Validity Reports: a mandatory requirement for In Vitro Diagnostic Regulation (IVDR)

Sep 19, 2023

Related Insights

Video

Part 3: Risk-based Quality Management Video (RBQM) Series

Nov 11, 2021

Article

Decentralized trial tools and technologies are here to stay: A regulatory perspective

Jul 23, 2021

Video

Part 2: Risk-based Quality Management Video (RBQM) Series

Nov 11, 2021

Webinar

Accelerating delivery of radiopharmaceutical trials

Oct 3, 2025

Report

New Medicines, Novel Insights: Advancing rare disease drug development

May 22, 2023

Report

New Medicines, Novel Insights: Accelerating development of cell and gene therapies

May 22, 2023

Show more